Keyword: Teva buys Cephalon
News
11.05.2011
- Teva Pharmaceutical Industries, the world's largest generic drugmaker, met forecasts with a 14% rise in quarterly earnings on strong sales growth in Europe following last year's...
News
04.05.2011
- Valeant Pharmaceuticals, which dropped a $5.7 billion offer for Cephalon earlier this week, will actively pursue other large takeover deals, its chief executive said on Tuesday...
News
04.05.2011
- Teva Pharmaceutical Industries struck a deal to acquire U.S. specialty drugmaker Cephalon for nearly $7 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals...
